AA Financial Advisors »

Vertex Pharmaceuticals Incorporated shares owned by AA Financial Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by AA Financial Advisors from 13F filings

Historical chart of AA Financial Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by AA Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by AA Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $384k 846 453.36
2025-09-30 $298k 761 391.64
2025-06-30 $281k 632 445.20

More positions owned by AA Financial Advisors

Vanguard Index Fds Small Cp Etf (VB)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Index Fds Total Stk Mkt (VTI)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Capital Group Core Equity Et Shs Creation Uni (CGUS)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Commscope Hldg

View all positions for AA Financial Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated